Kalbe Farma Tbk (KLBF IJ) Stronger than the Storm
4Q18: Successes of Defensive Strategies KLBF, amid volatile USDIDR, succeeded to close 2018 by posting a stable growth
Timah Tbk (TINS) Remains Favorable amid Supportive Global Backdrop
Upbeat ASP Aligning with Uptrend of Global Tin Price TINS posted the growth of 13.5% y-y into IDR2.6 trillion in 4Q17’s
Bukit Asam Tbk (PTBA IJ) Buy high—Sell higher
PTBA’s premium price among peers From January 2018 to March 2019, PTBA’s price rallied by 62.5% as its peers’ prices
Summarecon Agung Tbk (SMRA) Hampered by Limited New Products
Deleveraging COGS, Leveraging Margin In 3Q18, SMRA cheered its outstanding performance, e.g., the growth of 3.6% y-y to
Indofood CBP Sukses Makmur Tbk (ICBP) Acceleration in Sales
Growth of 12% in 3Q18 Sales ICBP cheered the growth of 12% in sales from IDR8.97 trillion in 3Q17 to IDR10 trillion in
Semen Indonesia Tbk (SMGR) Challenges Incubate Synergies
Better Performance in 3Q18 In 3Q18, SMGR’s sales and net profit soared by 21.8% q-q to IDR8.15 trillion and 99.3% q-q
Kalbe Farma Tbk (KLBF) Banks on Rupiah Appreciation
Sales Growth of 5.5% y-y KLBF proved its brighter performing by striving to hit sales growth of 5.5% from IDR5 trillion
Indo Tambangraya Megah Tbk (ITMG IJ) Excellent Performance and Higher Expectancy
3Q18 Performance: Above Estimates In 3Q18, ITMG posted the revenue of USD606 million (+40.8% q-q or +46.1% y-y)—higher
Ramayana Lestari Sentosa Tbk (RALS) Still Banks on Cost Control
Boosted by SSSG Performance of September 2018 RALS’s 3Q18 revenues were at IDR1.50 trillion (+6.5% y-y): the highest
